Frontiers in Oncology (Sep 2023)

Regulation of iron metabolism and ferroptosis in cancer stem cells

  • Hailiang Wang,
  • Hailiang Wang,
  • Hailiang Wang,
  • Zhongyan Zhang,
  • Zhongyan Zhang,
  • Zhongyan Zhang,
  • Shiye Ruan,
  • Shiye Ruan,
  • Shiye Ruan,
  • Qian Yan,
  • Qian Yan,
  • Yubin Chen,
  • Yubin Chen,
  • Jinwei Cui,
  • Jinwei Cui,
  • Xinjian Wang,
  • Shanzhou Huang,
  • Shanzhou Huang,
  • Shanzhou Huang,
  • Shanzhou Huang,
  • Baohua Hou,
  • Baohua Hou,
  • Baohua Hou,
  • Baohua Hou

DOI
https://doi.org/10.3389/fonc.2023.1251561
Journal volume & issue
Vol. 13

Abstract

Read online

The ability of cancer stem cells (CSCs) to self-renew, differentiate, and generate new tumors is a significant contributor to drug resistance, relapse, and metastasis. Therefore, the targeting of CSCs for treatment is particularly important. Recent studies have demonstrated that CSCs are more susceptible to ferroptosis than non-CSCs, indicating that this could be an effective strategy for treating tumors. Ferroptosis is a type of programmed cell death that results from the accumulation of lipid peroxides caused by intracellular iron-mediated processes. CSCs exhibit different molecular characteristics related to iron and lipid metabolism. This study reviews the alterations in iron metabolism, lipid peroxidation, and lipid peroxide scavenging in CSCs, their impact on ferroptosis, and the regulatory mechanisms underlying iron metabolism and ferroptosis. Potential treatment strategies and novel compounds targeting CSC by inducing ferroptosis are also discussed.

Keywords